Broadcom
AVGO
Taiwan Semiconductor
TSM
Tesla
TSLA
ASML Holding
ASML
Qualcomm
QCOM
US Stock MarketDetailed Quotes
KPTI Karyopharm Therapeutics
- 0.700
- -0.024-3.31%
Close Dec 13 16:00 ET
- 0.707
- +0.007+1.00%
Post 19:52 ET
87.72MMarket Cap-0.67P/E (TTM)
0.735High0.692Low1.44MVolume0.710Open0.724Pre Close1.03MTurnover1.27%Turnover RatioLossP/E (Static)125.31MShares1.95052wk High-0.55P/B79.71MFloat Cap0.65552wk Low--Dividend TTM113.87MShs Float49.005Historical High--Div YieldTTM5.93%Amplitude0.617Historical Low0.711Avg Price1Lot Size
Karyopharm Therapeutics News
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.
Karyopharm Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Abate Kristin
Karyopharm Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avidity Partners Management LP(3.7%),Avidity Partners Management (GP) LLC(3.7%), etc.
Karyopharm Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.13%)
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.
Karyopharm Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.13%)
Karyopharm Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Highbridge Capital Management, LLC(7.2%)
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mano Michael
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mason Michael
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cheng Sohanya Roshan
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Poulton Stuart
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.
Karyopharm Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(3.5%)
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director PAKIANATHAN DEEPIKA
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mason Michael
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director PAKIANATHAN DEEPIKA
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.